Use of Acellular Umbilical Cord-Derived Tissues in Corneal and Ocular Surface Diseases
Blood derived products have become a valuable source of tissue for the treatment of ocular surface diseases that are refractory to conventional treatments. These can be obtained from autologous or allogeneic sources (patient’s own blood or from healthy adult donors/umbilical cord blood, respectively...
Main Authors: | Arianna A. Tovar, Ian A. White, Alfonso L. Sabater |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Medicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2305-6320/8/2/12 |
Similar Items
-
Toxicological Profile of Umbilical Cord Blood-Derived Small Extracellular Vesicles
by: Silvia C. Rodrigues, et al.
Published: (2021-08-01) -
Improving engraftment and immune reconstitution in umbilical cord blood transplantation
by: Robert eDanby, et al.
Published: (2014-02-01) -
Factors Influencing the Umbilical Cord Blood Stem Cell Industry: An Evolving Treatment Landscape
by: Carla Dessels, et al.
Published: (2018-09-01) -
Immunomodulatory Properties of Umbilical Cord Blood-Derived Small Extracellular Vesicles and Their Therapeutic Potential for Inflammatory Skin Disorders
by: Sílvia C. Rodrigues, et al.
Published: (2021-09-01) -
Study of Topical Human Umbilical Cord Blood Serum in the Treatment of Alkaline Corneal Epithelial Wounds in Rabbit Model
by: B Sharifi, et al.
Published: (2011-04-01)